The big biotech opportunity

They say health is wealth, but healthcare investors might disagree. The sector has had a tough time over the past few years. Policy noise in the US has been a major headwind recently, but even before

AI, CHIPS AND INTELLIGENT INFRASTRUCTURE

The names which take the Shares team’s fancy

In 2026, the FTSE 100 index is likely to pass 10,000 for the first time thanks to the onward march of corporate earnings around the globe. UK investors have been remarkably reluctant to invest despite

Britain’s investment establishment is firmly convinced that the US market – and in particular the technology-centric “Magnificent Seven” stocks – are an investment bubble that is destined to implode a

Companies in the news and how they were assessed